Epidemiological Trends in NASH as a Cause for Liver Transplant

Current Hepatology Reports

Volumn 15, Issue 2, 2016, Pages 67-74

  Siow, Way ^a,b   van der Poorten, David ^a,b   George, Jacob ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Diabetes; Epidemiology; Liver transplantation; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Obesity

Indexed keywords

EID: 85020923874     PISSN: None     EISSN: 21959595     Source Type: Journal    
DOI: 10.1007/s11901-016-0294-x     Document Type: Article

References (77)

1. R. Loomba A.J. Sanyal The global NAFLD epidemic Nat Rev Gastroenterol Hepatol 2013 10 11 686 90 1:CAS:528:DC%2BC3sXhsVyntb%2FK 10.1038/nrgastro.2013.171 24042449
2. M. Blachier H. Leleu M. Peck-Radosavljevic et al. The burden of liver disease in Europe: a review of available epidemiological data J Hepatol 2013 58 3 593 608 10.1016/j.jhep.2012.12.005 23419824
3. G. Bedogni L. Miglioli F. Masutti et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study Hepatology 2005 42 1 44 52 10.1002/hep.20734 15895401
4. N. Chalasani Z. Younossi J.E. Lavine et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology 2012 55 6 2005 23 10.1002/hep.25762 22488764
5. G. Marchesini M. Brizi G. Bianchi et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 2001 50 8 1844 50 1:CAS:528:DC%2BD3MXlslKmsr4%3D 10.2337/diabetes.50.8.1844 11473047
6. S. Chitturi S. Abeygunasekera G.C. Farrell et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 2002 35 2 373 9 1:CAS:528:DC%2BD38XhsVGrt74%3D 10.1053/jhep.2002.30692 11826411
7. D.E. Kleiner E.M. Brunt M. Van Natta et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 2005 41 6 1313 21 10.1002/hep.20701 15915461
8. N. Rafiq C. Bai Y. Fang et al. Long-term follow-up of patients with nonalcoholic fatty liver Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 2009 7 2 234 8 10.1016/j.cgh.2008.11.005
9. C.K. Argo S.H. Caldwell Epidemiology and natural history of non-alcoholic steatohepatitis Clin Liver Dis 2009 13 4 511 31 10.1016/j.cld.2009.07.005 19818302
10. J. Jinks B. Hillner A. Sanyal A decision analysis of the value of liver biopsy in nonalcoholic fatty liver disease (NAFLD) Gastroenterology 2006 130 4 A824 5
11. P. Angulo J.M. Hui G. Marchesini et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD Hepatology 2007 45 4 846 54 1:CAS:528:DC%2BD2sXltlWis7k%3D 10.1002/hep.21496 17393509
12. S. Saadeh Z.M. Younossi E.M. Remer et al. The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 2002 123 3 745 50 10.1053/gast.2002.35354 12198701
13. A.E. Feldstein A. Wieckowska A.R. Lopez et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study Hepatology 2009 50 4 1072 8 1:CAS:528:DC%2BD1MXhtlWlu7jL 10.1002/hep.23050 19585618 2757511
14. L.A. Adams K.D. Lindor Nonalcoholic fatty liver disease Ann Epidemiol 2007 17 11 863 9 10.1016/j.annepidem.2007.05.013 17728149
15. M. Lazo R. Hernaez S. Bonekamp et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study BMJ 2011 343 d6891 10.1136/bmj.d6891 22102439 3220620
16. H.T. Sorensen S. Friis J.H. Olsen et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark Hepatology 1998 28 4 921 5 1:STN:280:DyaK1cvivFGnuw%3D%3D 10.1002/hep.510280404 9755226
17. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81. A systematic analysis of a large number of surveys, reports and published studies (n = 1769) on worldwide obesity rates.
18. The global burden of disease: 2004 update. 2008.
19. K.L. Rennie S.A. Jebb Prevalence of obesity in Great Britain Obes Rev: Off J Int Assoc Study Obes 2005 6 1 11 2 1:STN:280:DC%2BD2M%2FivVOgug%3D%3D 10.1111/j.1467-789X.2005.00164.x
20. J.J. Varo M.A. Martinez-Gonzalez J.A. Martinez Obesity prevalence in Europe Anales del sistema sanitario de Navarra 2002 25 Suppl 1 103 8 12861274
21. OECD. Health at a Glance: Europe 2012: OECD Publishing.
22. J. Shen A. Goyal L. Sperling The emerging epidemic of obesity, diabetes, and the metabolic syndrome in China Cardiol Res Pract 2012 2012 178675 21961074 3179874
23. W.P. Jia C. Wang S. Jiang et al. Characteristics of obesity and its related disorders in China Biomed Environ Sci: BES 2010 23 1 4 11 1:CAS:528:DC%2BC3cXlt1OlsbY%3D 10.1016/S0895-3988(10)60025-6 20486430
24. Z. Li J. Xue P. Chen et al. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies J Gastroenterol Hepatol 2014 29 1 42 51 1:CAS:528:DC%2BC3sXhvFejt73L 10.1111/jgh.12428 24219010
25. K.M. Flegal M.D. Carroll B.K. Kit et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010 Jama 2012 307 5 491 7 10.1001/jama.2012.39 22253363
26. L. Guariguata D.R. Whiting I. Hambleton et al. Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res Clin Pract 2014 103 2 137 49 1:STN:280:DC%2BC2crjs1Ogsg%3D%3D 10.1016/j.diabres.2013.11.002 24630390
27. N. Holman B. Young R. Gadsby What is the current prevalence of diagnosed and yet to be diagnosed diabetes in the UK Diabet Med: J Br Diabet Assoc 2014 31 5 510 1 1:STN:280:DC%2BC2cznvVGrsw%3D%3D 10.1111/dme.12397
28. Menke A, Casagrande S, Geiss L, et al. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. Jama. 2015;314(10):1021–9. A population-based study examining prevalence and trends of diabetes in the USA from the NHANES database.
29. S.P.O. Jansson K. Fall O. Brus et al. Prevalence and incidence of diabetes mellitus: a nationwide population-based pharmaco-epidemiological study in Sweden Diabet Med 2015 32 10 1319 28 1:STN:280:DC%2BC2MrjvVCktw%3D%3D 10.1111/dme.12716 25662570
30. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362(12):1090–101. A large (n = 46,239) population based national study from China highlighting the alarming trends for diabetes.
31. Yoon KH, Lee JH, Kim JW, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368(9548):1681–8. A review artice summarising global prevalence rates of obesity and diabetes, with a focus on Asian countries.
32. M.A. Rahim A. Hussain A.K. Azad Khan et al. Rising prevalence of type 2 diabetes in rural Bangladesh: a population based study Diabetes Res Clin Pract 2007 77 2 300 5 1:STN:280:DC%2BD2s3ntVKkuw%3D%3D 10.1016/j.diabres.2006.11.010 17187890
33. A. Ramachandran C. Snehalatha A. Kapur et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey Diabetologia 2001 44 9 1094 101 1:CAS:528:DC%2BD3MXmtlWltr4%3D 10.1007/s001250100627 11596662
34. N. Saquib J. Saquib T. Ahmed et al. Cardiovascular diseases and type 2 diabetes in Bangladesh: a systematic review and meta-analysis of studies between 1995 and 2010 BMC Public Health 2012 12 434 10.1186/1471-2458-12-434 22694854 3487781
35. H. Lydatakis I.P. Hager E. Kostadelou et al. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease Liver Int: Off J Int Assoc Study Liver 2006 26 7 864 71 1:CAS:528:DC%2BD28XhtVegsrjJ 10.1111/j.1478-3231.2006.01312.x
36. C. Wah-Kheong G. Khean-Lee Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease Hepatol Int 2013 7 1 65 71 10.1007/s12072-012-9384-1 26201622
37. S. Jimba T. Nakagami M. Takahashi et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults Diabet Med: J Br Diabet Assoc 2005 22 9 1141 5 1:CAS:528:DC%2BD2MXhtVOlt7%2FO 10.1111/j.1464-5491.2005.01582.x
38. J.G. Fan G.C. Farrell Epidemiology of non-alcoholic fatty liver disease in China J Hepatol 2009 50 1 204 10 10.1016/j.jhep.2008.10.010 19014878
39. V.W. Wong Nonalcoholic fatty liver disease in Asia: a story of growth J Gastroenterol Hepatol 2013 28 1 18 23 10.1111/jgh.12011 23094755
40. Lazo M, Hernaez R, Eberhardt MS, et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2013;178(1):38–45. A population-based study with data from the US NHANES demonstrating trends in NAFLD.
41. Z.M. Younossi M. Stepanova M. Afendy et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008 Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 2011 9 6 524 30 e1 10.1016/j.cgh.2011.03.020 quiz e60
42. C.D. Williams J. Stengel M.I. Asike et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 2011 140 1 124 31 10.1053/j.gastro.2010.09.038 20858492
43. F. Harnois S. Msika J.M. Sabate et al. Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery Obes Surg 2006 16 2 183 8 10.1381/096089206775565122 16469221
44. C. Boza A. Riquelme L. Ibanez et al. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass Obes Surg 2005 15 8 1148 53 10.1381/0960892055002347 16197788
45. P. Colicchio G. Tarantino F. del Genio et al. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy Ann Nutr Metab 2005 49 5 289 95 1:CAS:528:DC%2BD2MXpvFGrtLY%3D 10.1159/000087295 16088092
46. M. Machado P. Marques-Vidal H. Cortez-Pinto Hepatic histology in obese patients undergoing bariatric surgery J Hepatol 2006 45 4 600 6 10.1016/j.jhep.2006.06.013 16899321
47. S.J. De Hewavisenthi A.S. Dassanayaka H.J. De Silva Clinical, biochemical and histological characteristics of a Sri Lankan population of non-alcoholic steatohepatitis (NASH) patients Ceylon Med J 2005 50 3 113 6 16252575
48. S. Mittal H.B. El-Serag Y.H. Sada et al. Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 2016 14 1 124 31 e1 1:CAS:528:DC%2BC2MXhsl2msrrE 10.1016/j.cgh.2015.07.019
49. L.A. Adams J.F. Lymp J. St Sauver et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 2005 129 1 113 21 10.1053/j.gastro.2005.04.014 16012941
50. G.C. Farrell C.Z. Larter Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 2006 43 2 Suppl 1 S99 112 1:CAS:528:DC%2BD28XhvVSktLo%3D 10.1002/hep.20973 16447287
51. Bhala N, Angulo P, van der Poorten D, et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology. 2011;54(4):1208–16. An international collaborative study highlighting the long-term sequelae from NAFLD, including from end-stage liver disease and HCC.
52. Angulo P, Bugianesi E, Bjornsson ES, et al. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2013;145(4):782–9 e4. A multicentre study demonstrating the validity of non-invasive strategies in predicting long-term outcomes in NAFLD.
53. J. Xiong J. Wang J. Huang et al. Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study Clinics 2015 70 8 563 8 10.6061/clinics/2015(08)06 26247669 4518765
54. S. Mittal H.B. El-Serag Epidemiology of hepatocellular carcinoma: consider the population J Clin Gastroenterol 2013 47 Suppl S2 6 10.1097/MCG.0b013e3182872f29 23632345 3683119
55. M.S. Ascha I.A. Hanouneh R. Lopez et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 2010 51 6 1972 8 10.1002/hep.23527 20209604
56. A. Sanyal A. Poklepovic E. Moyneur et al. Population-based risk factors and resource utilization for HCC: US perspective Curr Med Res Opin 2010 26 9 2183 91 1:STN:280:DC%2BC3cjkslyhug%3D%3D 10.1185/03007995.2010.506375 20666689
57. J.P. Ong A. Pitts Z.M. Younossi Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease J Hepatol 2008 49 4 608 12 10.1016/j.jhep.2008.06.018 18682312
58. D.L. White F. Kanwal H.B. El-Serag Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 2012 10 12 1342 59 e2 10.1016/j.cgh.2012.10.001
59. K. Yasui E. Hashimoto Y. Komorizono et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 2011 9 5 428 33 10.1016/j.cgh.2011.01.023
60. H.B. El-Serag F. Kanwal Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology 2014 60 5 1767 75 10.1002/hep.27222 24839253 4211957
61. H.B. El-Serag H. Hampel F. Javadi The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 2006 4 3 369 80 10.1016/j.cgh.2005.12.007
62. P. Wang D. Kang W. Cao et al. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis Diabetes Metab Res Rev 2012 28 2 109 22 10.1002/dmrr.1291 21898753
63. S.C. Larsson A. Wolk Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies Br J Cancer 2007 97 7 1005 8 1:STN:280:DC%2BD2srovFSjsg%3D%3D 17700568 2360408
64. D.N. Amarapurkar M. Dharod S. Gautam et al. Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis Trop Gastroenterol: Off J Dig Dis Found 2013 34 3 159 63 1:STN:280:DC%2BC2cjltlOltg%3D%3D 10.7869/tg.120
65. D.L. White S. Tavakoli-Tabasi J. Kuzniarek et al. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males Hepatology 2012 55 3 759 68 1:CAS:528:DC%2BC38Xislahsr4%3D 10.1002/hep.24618 21858849 3399504
66. Wong RJ, Cheung R, Ahmed A. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology. 2014;59(6):2188–95. A study from the USA of a cohort of more than 60,000 liver transplants recorded on the UNOS database over 10 years assessing epidemiological trends in transplants and comparing trends in different aetiologies of liver disease.
67. J.A. Marrero R.J. Fontana G.L. Su et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 2002 36 6 1349 54 10.1002/hep.1840360609 12447858
68. M. Charlton P. Kasparova S. Weston et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease Liver Transpl: Off Publ Am Assoc Study Liver Dis Int Liver Transpl Soc 2001 7 7 608 14 1:STN:280:DC%2BD3MvhtFymsw%3D%3D 10.1053/jlts.2001.25453
69. M.R. Charlton J.M. Burns R.A. Pedersen et al. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States Gastroenterology 2011 141 4 1249 53 10.1053/j.gastro.2011.06.061 21726509
70. Alkhouri N, Hanouneh IA, Zein NN. et al. Liver transplantation for nonalcoholic steatohepatitis (NASH) in young patients. Transplant international: official journal of the European Society for Organ Transplantation. 2015.
71. Adam R, Karam V, Delvart V, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol. 2012;57(3):675–88. Liver transplantation statistics and trends from Europe.
72. Wang H, Jiang W, Zhou Z, et al. Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report. Hepatobiliary Surg Nutr. 2013;2(4):188–97. Liver transplantation statistics and trends from China.
73. V. de Villa C.M. Lo Liver transplantation for hepatocellular carcinoma in Asia Oncologist 2007 12 11 1321 31 10.1634/theoncologist.12-11-1321 18055852
74. Lynch S BG. ANZLT Registry Report 2014. Australia and New Zealand Liver Transplant Registry. 2014. Liver transplantation statistics and trends from Australia and New Zealand.
75. Howell J, Balderson G, Hellard M, et al. The increasing burden of potentially preventable liver disease among adult liver transplant recipients: a comparative analysis of liver transplant indication by era in Australia and New Zealand. J Gastroenterol Hepatol. 2015.
76. A. Afzali K. Berry G.N. Ioannou Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States Liver Transpl: Off Publ Am Assoc Study Liver Dis Int Liver Transpl Soc 2012 18 1 29 37 10.1002/lt.22435
77. N. Kemmer G.W. Neff E. Franco et al. Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation Transplantation 2013 96 10 860 2 1:CAS:528:DC%2BC3sXhvVSmsL7J 24247899